- Home
- PFE vs SKIN Comparison
PFE vs SKIN Comparison
Compare PFE & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- SKIN
- Stock Information
- Founded
- PFE 1849
- SKIN 1997
- Country
- PFE United States
- SKIN United States
- Employees
- PFE N/A
- SKIN N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- SKIN Package Goods/Cosmetics
- Sector
- PFE Health Care
- SKIN Consumer Discretionary
- Exchange
- PFE Nasdaq
- SKIN Nasdaq
- Market Cap
- PFE 134.2B
- SKIN N/A
- IPO Year
- PFE N/A
- SKIN N/A
- Fundamental
- Price
- PFE $23.42
- SKIN $1.64
- Analyst Decision
- PFE Hold
- SKIN Hold
- Analyst Count
- PFE 14
- SKIN 3
- Target Price
- PFE $29.92
- SKIN $1.42
- AVG Volume (30 Days)
- PFE 45.6M
- SKIN 1.2M
- Earning Date
- PFE 04-29-2025
- SKIN 05-08-2025
- Dividend Yield
- PFE 7.32%
- SKIN N/A
- EPS Growth
- PFE N/A
- SKIN N/A
- EPS
- PFE 1.38
- SKIN N/A
- Revenue
- PFE $62,464,000,000.00
- SKIN $322,471,000.00
- Revenue This Year
- PFE N/A
- SKIN N/A
- Revenue Next Year
- PFE N/A
- SKIN $6.06
- P/E Ratio
- PFE $17.02
- SKIN N/A
- Revenue Growth
- PFE 11.65
- SKIN N/A
- 52 Week Low
- PFE $20.92
- SKIN $0.78
- 52 Week High
- PFE $31.54
- SKIN $2.29
- Technical
- Relative Strength Index (RSI)
- PFE 51.18
- SKIN 53.87
- Support Level
- PFE $23.11
- SKIN $1.53
- Resistance Level
- PFE $23.62
- SKIN $1.75
- Average True Range (ATR)
- PFE 0.46
- SKIN 0.16
- MACD
- PFE 0.09
- SKIN -0.01
- Stochastic Oscillator
- PFE 79.48
- SKIN 47.62
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.